Abstract

Ceruloplasmin (CP) is a plasma glycoprotein that transports copper throughout the body. In previous studies (Yang, F., Naylor, S., Lum, J., Cutshaw, S., McCombs, J., Naberhaus, K., McGill, J., Adrian, G., Moore, C., Barnett, D., and Bowman, B. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 3277-3261), two CP cDNA clones, CP-1 and CP-2, from a human cDNA library, differed from each other by the presence or absence, respectively, of 12 nucleotide bases encoding a deduced sequence of Gly-Glu-Tyr-Pro near the carboxyl-terminal region of the ceruloplasmin molecule. Examination of genomic DNA demonstrates that the two CP mRNAs are produced from a single gene by alternative spliced patterns. The additional amino acids deduced in CP-1 are products of alternative splicing within an intron of the CP gene at a site 12 nucleotide bases 3' to the commonly used site of CP-2. The CP-1 mRNA transcript encoding four extra amino acids appeared as a minor species accompanying CP-2 mRNA in placenta and chondrocytes. CP-1 mRNA was the predominant CP transcript in a lymphoblastic leukemia cell line, CEM. The mRNA examined from other tissues contained only CP-2 mRNA transcripts. These findings predict that alternative RNA splicing may lead to the differential expression of CP genomic sequences and produce alternate isoforms from a single CP gene in specific tissues.

Highlights

  • The additional amino acids deduced in CP- 1 are products of alternative splicing within an intron of the CP gene at a site 12 nucleotide bases 3’ to the commonly used site of CP-2

  • The results from this study demonstrated that the tissue specificity of ceruloplasmin extended to cartilage, chondrocytes, and glioma cells, tissues that were found to express significant amounts of CP mRNA

  • Two different mRNA transcripts encoding human

Read more

Summary

Introduction

Examination of genomic DNA demonstrates that the two CP mRNAs are produced from a single gene by alternative spliced patterns. The additional amino acids deduced in CP- 1 are products of alternative splicing within an intron of the CP gene at a site 12 nucleotide bases 3’ to the commonly used site of CP-2. The mRNA examined from other tissues contained only CP-2 mRNA transcripts. RNA splicing may lead to the differential expression of CP genomic sequences and produce alternate isoforms from a single. Sequences of the CP gene have contributed to DNA-encoding human and bovine clotting factors VIII and porcine factor V [5].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.